01-12-2006 | ORIGINAL
Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment
Published in: Acta Diabetologica | Issue 4/2006
Login to get access01-12-2006 | ORIGINAL
Published in: Acta Diabetologica | Issue 4/2006
Login to get access